UK markets open in 53 minutes
NIKKEI 225
39,099.94 +482.84 (+1.25%) HANG SENG
18,856.62 -338.98 (-1.77%) CRUDE OIL
76.95 -0.62 (-0.80%) GOLD FUTURES
2,361.60 -31.30 (-1.31%) DOW
39,671.04 -201.95 (-0.51%) Bitcoin GBP
54,542.39 -453.08 (-0.82%)
scPharmaceuticals Inc. (SCPH)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 3.8250 |
| Open | 3.8300 |
| Bid | 3.4900 x 100 |
| Ask | 3.5600 x 400 |
| Day's range | 3.4600 - 3.9400 |
| 52-week range | 3.4600 - 11.7500 |
| Volume | |
| Avg. volume | 233,064 |
| Market cap | 127.633M |
| Beta (5Y monthly) | 0.09 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.4800 |
| Earnings date | 08 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 19.50 |
- Thomson Reuters StreetEvents
Q1 2024 scPharmaceuticals Inc Earnings Call
Q1 2024 scPharmaceuticals Inc Earnings Call
- GuruFocus.com
scPharmaceuticals Inc (SCPH) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
Despite a net loss and increased operational costs, scPharmaceuticals Inc (SCPH) reports significant progress in product development and market expansion.
ZacksScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Lags Revenue Estimates
scPharmaceuticals (SCPH) delivered earnings and revenue surprises of 20% and 6.17%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.